Prestige Consumer Healthcare Inc.

Good day, and thank you for standing by. Welcome to the Q2 2026 Prestige Consumer Healthcare Inc. Earnings Conference Call. At this time, our participants are in the listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Phil Turper-Lilley, Vice President of Investor Relations and Treasury. Please go ahead.

Phil Turper- Thanks, Operator, and thank you to everyone who has joined today. On the call with me are Ron Lombardi, our chairman, president, and CEO, and Christine Sacco, our CFO and COO. On today's call, we'll review our second quarter fiscal 2026 results, discuss our full year outlook, and then take questions from analysts. A slide presentation accompanies today's call can be accessed by visiting PrestigeConsumerHealthcare.com, clicking on the Investors link, and then on today's webcast and presentation. Remember, some of the information contained in the presentation today includes non-GAAP financial measures. Reconciliations to the nearest GAAP financial measures are included in our earnings release and slide presentation. On today's call, management will make forward-looking statements around risks and uncertainties, which are detailed in a complete safe harbor disclosure on page two of the slide presentation that accompanies the call. These are important to review and contemplate. Business environment uncertainty remains heightened due to supply chain constraints, high inflation, and geopolitical events, each of which have numerous potential impacts. This means results could change at any time, and the forecasted impact of risk considerations is a best estimate based on the information available as of today's date. Further information concerning risk factors and cautionary statements are available in our most recent SEC filings and most recent company 10-K. I'll now turn it over to our CEO, Ron Lombardi. Ron?

Thanks Phil, let's begin on slide five. Our Q2 results exceeded the expectations we communicated back in August thanks to certain timing factors. Sales of 274 million declined versus the prior year but were better than forecast due to the timing of clear eyes supply and accelerated e-commerce shipments late in the quarter that outpaced consumption. We expect these timing factors to come out of Q3 and still expect a second half improvement in eye care supply previously discussed that underpins our full year forecast. I'll review our Q3 and full year outlook in detail later. Aside from these timing factors, our base business continues to perform well, benefiting from diversity of our portfolio and channels. we continue to experience double-digit e-commerce consumption growth thanks to the long-term investments previously discussed. Moving down the P&L, gross margin was largely as anticipated. Adjusted EPS of $1.07 was similar to the prior year, but ahead of expectations due to the sales beat. Lastly, Our financial profile continues to generate strong free cash flow, which was $134 million for the first half, up 10% versus the prior year. This valuable cash flow and our favorable leverage ratio enables multiple ways to create value for our business. For example, in Q2, we maintained our leverage ratio of 2.4 times while repurchasing over 1.1 million shares. And we continue to see additional opportunities for capital deployment that can enhance shareholder value. Now let's turn to page six for a review of our Dentec brand and how we are expanding the brand's reach in the dental care market. Dentek participates in the niche peg sections of a much larger oral care category. Our product offerings are diverse and include dental guards, floss picks, interdental brushes, and numerous dental accessories, such as temporary tooth fillings. The wide-ranging portfolio is geared towards the dental care enthusiast, offering technology-focused solutions to meet oral care needs. Like all of our brands, Dentec's emphasis is behind differentiated product offerings where we can use long-term brand building to drive sales growth at attractive margins. With that in mind, our largest focus within the Dentec portfolio is around dental guards, which today represents well over half of the brand's revenue. By leveraging the brand's number one share in combination with innovation and proven brand building tactics, we've been able to drive category growth and as a byproduct, our market share, which now exceeds 50% of the category. On the right side of the page, you'll see the most recent example of this proven marketing playbook, the Fantasy Guards marketing campaign. Fantasy football consumes an estimated 1.2 billion hours of time annually with fierce rivalry and competition. This results in untold stress to players and fans experiencing physical symptoms including teeth clenching and jaw pain. Dentek interjects itself in a witty way, allowing for fantasy football leagues to enter a sweepstakes and win an embarrassing grand prize finale for their lowest scorer. Launched in Q2 with the backing of former and current NFL players, the campaign is designed to connect Dentech with both new and existing consumers in a culturally relevant way. Engagement is broad-based across all the various marketing channels. The results are early, but showing solid success with an over five percentage point gain over last year in Dentech Guard's market share. So in summary, through brand building behind Dentec's most differentiated products like dental guards, the brand continues to grow sales and market share and is set up well for continued long-term growth. With that, I'll turn it over to Chris to discuss the financials.